CN116694601A - 蝰属磷脂酶a2特征多肽及其应用 - Google Patents
蝰属磷脂酶a2特征多肽及其应用 Download PDFInfo
- Publication number
- CN116694601A CN116694601A CN202310724694.2A CN202310724694A CN116694601A CN 116694601 A CN116694601 A CN 116694601A CN 202310724694 A CN202310724694 A CN 202310724694A CN 116694601 A CN116694601 A CN 116694601A
- Authority
- CN
- China
- Prior art keywords
- phospholipase
- sample
- characteristic
- viper
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 46
- 229920001184 polypeptide Polymers 0.000 title claims abstract description 39
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 39
- 108010058864 Phospholipases A2 Proteins 0.000 title claims abstract description 38
- 102100037611 Lysophospholipase Human genes 0.000 title claims abstract description 36
- 241000271025 Vipera Species 0.000 title description 9
- 241000271897 Viperidae Species 0.000 claims abstract description 30
- 241000894007 species Species 0.000 claims abstract description 12
- 238000002347 injection Methods 0.000 claims abstract description 11
- 239000007924 injection Substances 0.000 claims abstract description 11
- 238000001514 detection method Methods 0.000 claims abstract description 8
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract description 6
- 150000002500 ions Chemical class 0.000 claims description 18
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 12
- 239000012071 phase Substances 0.000 claims description 8
- 239000000243 solution Substances 0.000 claims description 8
- 239000012490 blank solution Substances 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 6
- 102000004142 Trypsin Human genes 0.000 claims description 6
- 108090000631 Trypsin Proteins 0.000 claims description 6
- 238000010828 elution Methods 0.000 claims description 6
- 235000019253 formic acid Nutrition 0.000 claims description 6
- 239000007791 liquid phase Substances 0.000 claims description 6
- 239000012588 trypsin Substances 0.000 claims description 6
- 108091005804 Peptidases Proteins 0.000 claims description 5
- 239000004365 Protease Substances 0.000 claims description 5
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 5
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 claims description 4
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 claims description 4
- 235000012538 ammonium bicarbonate Nutrition 0.000 claims description 4
- 239000001099 ammonium carbonate Substances 0.000 claims description 4
- 230000000415 inactivating effect Effects 0.000 claims description 4
- 230000002779 inactivation Effects 0.000 claims description 4
- 238000004949 mass spectrometry Methods 0.000 claims description 4
- 239000006228 supernatant Substances 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- XBJFCYDKBDVADW-UHFFFAOYSA-N acetonitrile;formic acid Chemical compound CC#N.OC=O XBJFCYDKBDVADW-UHFFFAOYSA-N 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 239000000047 product Substances 0.000 claims description 3
- 238000004704 ultra performance liquid chromatography Methods 0.000 claims description 3
- 239000003643 water by type Substances 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 claims description 2
- 238000012544 monitoring process Methods 0.000 claims description 2
- 238000012360 testing method Methods 0.000 claims description 2
- 239000003998 snake venom Substances 0.000 abstract description 9
- 239000003814 drug Substances 0.000 abstract description 5
- 229940079593 drug Drugs 0.000 abstract description 5
- 238000004458 analytical method Methods 0.000 abstract description 4
- 230000000144 pharmacologic effect Effects 0.000 abstract description 3
- 238000003908 quality control method Methods 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- 239000000523 sample Substances 0.000 description 25
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- 238000001819 mass spectrum Methods 0.000 description 9
- 239000002821 viper venom Substances 0.000 description 8
- 238000000034 method Methods 0.000 description 7
- 101710154606 Hemagglutinin Proteins 0.000 description 5
- 101710093908 Outer capsid protein VP4 Proteins 0.000 description 5
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 5
- 102000007079 Peptide Fragments Human genes 0.000 description 5
- 108010033276 Peptide Fragments Proteins 0.000 description 5
- 101710176177 Protein A56 Proteins 0.000 description 5
- 239000000185 hemagglutinin Substances 0.000 description 5
- 239000002435 venom Substances 0.000 description 5
- 231100000611 venom Toxicity 0.000 description 5
- 210000001048 venom Anatomy 0.000 description 5
- 241001449342 Chlorocrambe hastata Species 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 239000012488 sample solution Substances 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 description 3
- 102000015439 Phospholipases Human genes 0.000 description 3
- 108010064785 Phospholipases Proteins 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 150000003904 phospholipids Chemical class 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 241001505404 Deinagkistrodon acutus Species 0.000 description 2
- 102000018697 Membrane Proteins Human genes 0.000 description 2
- 108010052285 Membrane Proteins Proteins 0.000 description 2
- 108010026552 Proteome Proteins 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 238000011033 desalting Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 238000013467 fragmentation Methods 0.000 description 2
- 238000006062 fragmentation reaction Methods 0.000 description 2
- 229960000789 guanidine hydrochloride Drugs 0.000 description 2
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 2
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 238000005173 quadrupole mass spectroscopy Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 241000271506 Bothrops Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000698899 Daboia siamensis Species 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000271042 Gloydius halys Species 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 101001114133 Naja sputatrix Neutral phospholipase A2 muscarinic inhibitor Proteins 0.000 description 1
- 206010029350 Neurotoxicity Diseases 0.000 description 1
- 241001474977 Palla Species 0.000 description 1
- 241000337661 Parada Species 0.000 description 1
- 206010044221 Toxic encephalopathy Diseases 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004129 fatty acid metabolism Effects 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 208000031169 hemorrhagic disease Diseases 0.000 description 1
- 238000004896 high resolution mass spectrometry Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000007124 immune defense Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- PGLTVOMIXTUURA-UHFFFAOYSA-N iodoacetamide Chemical compound NC(=O)CI PGLTVOMIXTUURA-UHFFFAOYSA-N 0.000 description 1
- 230000037427 ion transport Effects 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 238000006198 methoxylation reaction Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000002552 multiple reaction monitoring Methods 0.000 description 1
- 230000003274 myotonic effect Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000007135 neurotoxicity Effects 0.000 description 1
- 231100000228 neurotoxicity Toxicity 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000006916 protein interaction Effects 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000005932 reductive alkylation reaction Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/18—Carboxylic ester hydrolases (3.1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/01—Carboxylic ester hydrolases (3.1.1)
- C12Y301/01004—Phospholipase A2 (3.1.1.4)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/72—Mass spectrometers
- G01N30/7233—Mass spectrometers interfaced to liquid or supercritical fluid chromatograph
- G01N30/724—Nebulising, aerosol formation or ionisation
- G01N30/7266—Nebulising, aerosol formation or ionisation by electric field, e.g. electrospray
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N2030/022—Column chromatography characterised by the kind of separation mechanism
- G01N2030/027—Liquid chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
- G01N2333/918—Carboxylic ester hydrolases (3.1.1)
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Computational Biology (AREA)
- Food Science & Technology (AREA)
- Dispersion Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
本发明涉及化学分析定性检测技术领域，尤其涉及一种蝰属磷脂酶A2特征多肽及其应用。所述特征多肽氨基酸序列为LVEYSYSYR。该特征多肽可用于检测待测样品中特征多肽种属来源，检测准确度高，可以显著提高蛇毒血凝酶注射液的质量控制水平，确保产品临床用药的有效性和安全性。本发明所述特征多肽能够对样品中磷脂酶A2进行有效鉴别，一方面填补了蝰属磷脂酶A2种属鉴别的空白，另一方面也为磷脂酶A2更多药理学活性和临床应用的开发提供了保障。
Description
技术领域
本发明涉及化学分析定性检测技术领域，尤其涉及蝰属磷脂酶A2特征多肽及其应用。
背景技术
磷脂酶A2（phospholipase A2，PLA2） 几乎存在于所有蛇毒液中，是生物体膜上一种重要的含钙金属酶,能特异性地水解sn-3-磷酸甘油酯2位上酯酰键生成游离的脂肪酸和溶血磷脂，广泛参与多种生物进程如磷脂代谢、免疫防御和信号传导，因而成为研究脂肪酸代谢、磷脂膜结构、磷脂与膜蛋白相互作用以及膜蛋白结构与功能的重要工具酶。圆斑蝰（Daboia russelii siamensis），是蛇亚目蝰科蝰亚科蝰属下的一种有毒蝰蛇。研究表明圆斑蝰脂酶A2具有神经毒性、间接溶血，强肌坏死活性和细胞毒性。不同种属来源磷脂酶A2氨基酸序列存在差异，导致作用位点不同，表现出不一样的药理活性。目前市场中蛇毒血凝酶注射液的有效成分是从蝰蛇科蛇毒中提取的蛇毒血凝酶，可用于各种出血疾病。磷脂酶A2作为潜在的杂质，对制剂中磷脂酶控制对于提高药品质量，保证临床用药安全十分重要。目前磷脂酶A2检测多采用卵磷脂降解法检测磷脂酶活性，该方法操作复杂，灵敏度较低。因此开发一种简便快捷、具有鉴别的作用的方法对蝰属圆斑蝰蛇磷脂酶A2研究及蛇毒血凝酶注射液的质量控制十分重要。
液质联用技术拥有高灵敏度、高分辨率、高稳定性、高特异性和高效分离等特点，广泛应用于样品的定性定量分析之中。对于蛋白类样品的种属鉴别，重要是特征肽的筛选、前处理及质谱条件的优化，特征肽需要同时具有种属特异性、稳定性、质谱响应高等，后续针对该特征肽进行相应的前处理及液质条件优化。
发明内容
为解决上述技术问题，本发明的发明目的是提供蝰属磷脂酶A2特征多肽，所述特征多肽能够对样品中磷脂酶A2进行有效鉴别，填补了蝰属磷脂酶A2种属鉴别的空白。
为实现上述发明目的，本发明采用以下技术方案：
蝰属磷脂酶A2特征多肽，所述特征多肽氨基酸序列为LVEYSYSYR。
一种上述蝰属磷脂酶A2特征多肽的应用，所述特征多肽可用于鉴别磷脂酶A2的种属来源。
进一步地，上述鉴别方法采用以下步骤：
（1）取待测样品溶解，进行酶解灭活后作为待测样品溶液；
（2）水经过酶解处理，制备空白溶液；
（3）取步骤（1）所制备的待测样品溶液及步骤（2）所制备的空白溶液注入液相色谱-质谱仪，采用电喷雾正离子模式，进行多反应监测，以质荷比m/z 590.29→675.31及590.29→838.37作为特征多肽的检测离子对，以确定待测样品中是否含有蝰属磷脂酶A2特征多肽中的特征多肽；
（4）如果检测到上述特征多肽,则证明待测样品中含有磷脂酶A2且来源于蝰属；反之若则证明待测样品中不含有来源于蝰的磷脂酶A2。
进一步地，步骤（3）所述液相色谱-质谱仪中液相和质谱检测条件中，液相条件为：Waters ACQUITY UPLC BEH C18 色谱柱（50 mm*2.1 mm，1.7 μm）；流动相A：0.1%甲酸溶液流动相，B：0.1%甲酸乙腈；柱温：40℃；进样量：5 μL；流速：0.3 ml/min；按下表进行梯度洗脱：
。
进一步地，步骤（1）制备待测样品的具体操作为：
①待测样品溶解：待测样品用1%碳酸氢铵配制为浓度1 µg/µL；
②酶解：取步骤①溶解后样品100 µL，加2 µg蛋白酶于37℃过夜酶解，酶解结束后高温灭活；
③离心：最后取步骤②酶解灭活的样品，12000 rpm离心10 min，取上清液即得待测样品。
优选地，所述的蛋白酶为胰蛋白酶。
与现有技术相比，本发明具有以下有益效果：由于已知白眉蝮蛇、矛头蝮蛇、尖吻蝮蛇等蛇毒的磷脂酶A2氨基酸序列中不含有本发明所述的特征多肽，因此，该特征多肽可用于检测待测样品中磷脂酶A2特征多肽的种属来源，检测准灵敏度高，一方面填补了蛇毒血凝酶注射液质量标准的空白，可以显著提高其质量控制水平，确保产品临床用药的有效性和安全性；另一方面也为蝰属磷脂酶A2更多药理学活性和临床应用的开发提供了保障。
附图说明
构成本发明的一部分的说明书附图用来提供对本发明的进一步理解，本发明的示意性实施例及其说明用于解释本发明，并不构成对本发明的不当限定。以下，结合附图来详细说明本发明的实施方案，其中：
图1为实施例1中蝰属磷脂酶A2特征多肽 LVEYSYSYR二级质谱图；
图2为实施例2中空白溶液特征多肽提取离子色谱图；
图3为实施例2中矛头蝮蛇蛇毒特征多肽提取离子色谱图；
图4为实施例2中圆斑蝰蛇蛇毒特征多肽提取离子色谱图。
具体实施方式
在接下来的描述中进一步阐述了本发明的具体细节用于充分理解本发明。本发明中的说明书所使用的术语只是为了用于说明本发明的优点和特点，不是旨在于限制本发明。
除非另行定义，本发明中所使用的所有专业与科学术语属于本发明的技术领域的技术人员所理解的含义相同。如无特殊说明，本发明所使用的药品或试剂均按照产品说明书使用或采用所属领域的常规使用方法。现根据说明书附图和具体实施方式对本发明的技术方案作进一步说明。
实施例1 蝰属磷脂酶A2特征多肽的筛选和确定
（1）试剂耗材
试剂：甲酸、乙腈、碘代乙酰胺、胰蛋白酶（sigma）、盐酸胍（VETEC）、二硫苏糖醇（BBI Life Sciences），其它试剂均为分析纯。
仪器：超纯水仪（Milli_Q）、电子天平（METTLERTOLEDO）、冷冻干燥机（LABCONC）、离心浓缩仪（LABCONC）、高分辨质谱（Thermo Scientific，QEplus）、纳升液相系统（ThermoScientific, EASY-nLC 1000）。
（2）样品处理
样品溶解：圆斑蝰蛇粗毒取适量配置成1 µg/µL；
还原烷基化：取50 µL（1 µg/µL）样品溶液，加入80µL变性缓冲液（称0.606 gTris，8.04 mg EDTA，5.73 g盐酸胍，加水10 mL溶解，用HCl调pH至 8.1）及20 µL 1 M DTT，60℃反应30min；加入40 µL 1 M IA，避光反应30 min；
脱盐：10k超滤膜水洗一次后，加入还原烷基化样品，12000 rpm离心，加400µL12000 rpm离心，重复3次。
酶解：脱盐后样品加入100 µL 25 mM NH4HCO3溶解，加2 µg 胰蛋白酶于37℃过夜酶解，酶解结束后高温灭活并冻干；
复溶：最后加水500 µL复溶并混匀，12000 rpm离心10 min，取上清于进样瓶中进行液质联用分析；
（3）实验条件
色谱柱为赛默飞Acclaim PepMap®100 C18纳升色谱柱:75 μm×15 cm（3 μm,100Å）和100 µm ×2 cm（5 µm,100 Å）。
流动相A为2% 乙腈的0.1% 甲酸水溶液；流动相B为98% 乙腈的0.1% 甲酸水溶液；进样室温度7℃；进样体积2 µL。采用EASY-nLC 1000纳升液相系统分离。纳升分离泵流速为300 nL/min，梯度洗脱设置见表1。
质谱条件：采用正离子模式进行分析，喷雾电压为2.0 kV，离子传输毛细管温度为275 ℃，S-Lens传输效率设置为60%，采集范围为350-1,500。利用Top speed模式进行母离子选择，采用HCD模式进行碎裂，碎裂能量NCE设置为28%。
表1纳升液相-高分辨质谱梯度洗脱表
。
（4）Proteome Discoverer搜库
采用Proteome Discoverer2.5版本对质谱数据进行搜库，条件设置如下：蛋白序列数据库选择uniprot网站（https://www.uniprot.org/）中的蛇毒磷脂酶数据库；蛋白酶为胰蛋白酶；最大漏切位点设置为3；肽段长度6-144；肽段母离子质量偏差10 ppm，子离子0.02 Da；碎片类型为b/y离子；固定化修饰为半胱氨酸甲氧基化（+57.021 Da）；可变修饰选为甲硫氨酸氧化（+15.995 Da）；肽段验证是通过设定FDR≤0.01来控制肽段错误率，并选择可信度归属为“高”的肽段。
（5）特征多肽筛选
质谱结果中酸性磷脂酶A2 B亚基（Q7T3T5）和酸性磷脂酶A2 A亚基（Q7T2R1）覆盖率分别是87%和80%。对检测到的特征肽进行筛选，LVEYSYSYR作为蝰属磷脂酶A2特征多肽，与数据库Blast序列比对结果（图1），证明所述特征肽是蝰属圆斑蝰蛇及山蝰磷脂酶A2专有的，可用于磷脂酶A2的种属鉴别。
对蝰属圆斑蝰蛇粗毒中找到的特征多肽，通过高分辨质谱对其进行验证，均能通过Proteome Discoverer2.5匹配到相应肽段，其二级质谱图见图2。
实施例2 三重四级杆质谱法种属鉴别
1.样品制备
供试品溶液：待测样品用25 mM碳酸氢铵配制为浓度1 µg/µL；取样品溶液100 µL，加1 µg胰蛋白酶于37℃过夜酶解，酶解结束后高温灭活；12000 rpm离心10 min，取上清液即得待测样品。
空白溶液：取25 mM碳酸氢铵100 µL，同法制备。
2.实验方法
色谱柱： Waters ACQUITY UPLC BEH C18 色谱柱（50 mm*2.1 mm，1.7 µm）；流动相A：0.1%甲酸溶液流动相，B：0.1%甲酸乙腈；按表2进行梯度洗脱；柱温：40℃；进样量：2 µL；流速：0.3 ml/min。
表2 梯度洗脱表
。
质谱条件：电喷雾离子源（ESI），正离子扫描模式，多反应监测；涡旋离子喷雾温度：500℃；离子化电压：5.5 kV；碰撞室出口电压：10 V；入口电压（EP）10V；定性、定量离子对碰撞能量见表3。
表3 蝰属圆斑蝰蛇磷脂酶A2特征多肽质荷比及质谱条件设置
。
2.实验结果
取空白溶液、圆斑蝰蛇粗毒及矛头蝮蛇粗毒进行分析，空白溶液及矛头蝮蛇粗毒提取离子色谱图分别见图2和图3，在样品出峰位置没有干扰峰出现。圆斑蝰蛇粗毒提取离子色谱图见图4，特征多肽出峰时间为4.5 min，质谱响应良好。以上结果表明，该方法可用于圆斑蝰蛇粗毒磷脂酶A2种属鉴别。
分别取10批次含尖吻蝮蛇粗毒、10批次圆斑蝰蛇粗毒、10批次矛头蝮蛇粗毒及10批次白眉蝮蛇粗毒随机取样通过液相色谱-三重四级杆质谱法测进行分析，发现使用本发明所述的特征多肽可以百分百的鉴别出圆斑蝰蛇磷脂酶A2。
以上所述仅说明了本发明的几个实施方式，并不能因此而理解是对本发明专利范围的限制。应当指出，对于本领域的其他人员来说，在不脱离本发明的构思和范围的情况下，还可进行修改替换改进等，这些都属于本发明的保护范围。
Claims (6)
1.蝰属磷脂酶A2特征多肽，其特征在于，所述特征多肽氨基酸序列为LVEYSYSYR。
2.一种权利要求1所述蝰属磷脂酶A2特征多肽的应用，特征在于，所述特征多肽可用于鉴别磷脂酶A2的种属来源。
3.根据权利要求2所述的应用，其特征在于，鉴别采用以下步骤：
（1）取待测样品溶解，进行酶解灭活后作为待测品溶液；
（2）水经过酶解处理，制备空白溶液；
（3）取步骤（1）所制备的待测品溶液及步骤（2）所制备的空白溶液注入液相色谱-质谱仪，采用电喷雾正离子模式，进行多反应监测，以质荷比m/z 590.29→675.31及590.29→838.37作为特征多肽的检测离子对，以确定待测样品中是否含有蝰属磷脂酶A2特征多肽中的特征多肽；
（4）如果检测到权利要求1所述的特征多肽,则证明待测样品中含有磷脂酶A2且来源于蝰属；反之则证明待测样品中不含有来源于蝰属A2的磷脂酶A2。
4.根据权利要求3所述的应用，其特征在于，步骤（3）所述液相色谱-质谱仪中液相和质谱检测条件中，液相条件为：Waters ACQUITY UPLC BEH C18 色谱柱（50 mm*2.1 mm，1.7 μm）；流动相A：0.1%甲酸溶液流动相，B：0.1%甲酸乙腈；柱温：40℃；进样量：5 μL；流速：0.3ml/min；按下表进行梯度洗脱：
。
5.根据权利要求3所述的应用，其特征在于，步骤（1）所述的待测品溶液的具体制备方法为：
①待测样品溶解：待测样品用1%碳酸氢铵配制为浓度1 µg/µL；
②酶解：取步骤①溶解后样品100 µL，加2 µg蛋白酶于37℃过夜酶解，酶解结束后高温灭活；
③离心：最后取步骤②酶解灭活的样品，12000 rpm离心10 min，取上清液即得待测品溶液。
6.根据权利要求5所述的应用，其特征在于，所述的蛋白酶为胰蛋白酶。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310724694.2A CN116694601A (zh) | 2023-06-19 | 2023-06-19 | 蝰属磷脂酶a2特征多肽及其应用 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310724694.2A CN116694601A (zh) | 2023-06-19 | 2023-06-19 | 蝰属磷脂酶a2特征多肽及其应用 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN116694601A true CN116694601A (zh) | 2023-09-05 |
Family
ID=87827357
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202310724694.2A Pending CN116694601A (zh) | 2023-06-19 | 2023-06-19 | 蝰属磷脂酶a2特征多肽及其应用 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN116694601A (zh) |
-
2023
- 2023-06-19 CN CN202310724694.2A patent/CN116694601A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111896651B (zh) | 一种白眉蝮蛇蛇毒类凝血酶特征多肽及其应用 | |
| CN113307846A (zh) | 一种鉴别梅花鹿或马鹿鹿茸鹿角的特征多肽及其应用 | |
| CN111893110B (zh) | 一种白眉蛇毒血凝酶特征多肽及其在注射用蛇毒血凝酶种属鉴别中的应用 | |
| CN113480599A (zh) | 一种鉴别梅花鹿或马鹿鹿角胶的特征多肽及其应用 | |
| Kaufmann | Matrix-assisted laser desorption ionization (MALDI) mass spectrometry: a novel analytical tool in molecular biology and biotechnology | |
| US20220033873A1 (en) | Quantitative detection method for snake venom thrombin-like enzyme (svtle) | |
| CN102598204A (zh) | 通过质谱法检测分子的方法 | |
| CN112136043B (zh) | 用于检测和定量肝功能代谢产物的质谱测定方法 | |
| JP5276993B2 (ja) | 低分子量ペプチドの高感度定量方法 | |
| Nelson et al. | Peptide characterization using bioreactive mass spectrometer probe tips | |
| Wenner et al. | Factors that affect ion trap data-dependent MS/MS in proteomics | |
| CN117069801B (zh) | 一种尖刺信使蝎和条斑钳蝎共有特征多肽及其筛选方法 | |
| CN116814588B (zh) | 圆斑蝰蛇磷脂酶a2特征多肽及其应用 | |
| WO2018223076A1 (en) | Methods for absolute quantification of low-abundance polypeptides using mass spectrometry | |
| CN116694601A (zh) | 蝰属磷脂酶a2特征多肽及其应用 | |
| CN109557193B (zh) | 一种芝麻主要过敏原的质谱定性检测方法 | |
| CN113502279B (zh) | 一种蝮蛇蛇毒磷脂酶a2特征多肽及其应用 | |
| CN116217666A (zh) | 尖吻蝮蛇磷脂酶a2特征多肽组及其应用 | |
| CN111595971B (zh) | 一种灰尘中尘螨过敏原蛋白Der f1和Der p1及其硝化产物的检测方法 | |
| CN116297976B (zh) | 尿激酶特征多肽组及检测尿激酶掺假的方法 | |
| CN116675761A (zh) | 绒促性素特征多肽组及其应用 | |
| Migneault et al. | Two glutaraldehyde‐immobilized trypsin preparations for peptide mapping by capillary zone electrophoresis, liquid chromatography, and mass spectrometry | |
| CN104569124A (zh) | 鸡蛋质谱检测特征序列组及检测试剂盒 | |
| CN116500149A (zh) | 一种蚓激酶的超高效液相色谱-串联质谱鉴别方法 | |
| CN116462749B (zh) | 促肝细胞生长素特征多肽组及其应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |